Chromobacterium violaceum is a Gram-negative, facultativeanaerobic, non-sporing coccobacillus. It is motile with the help of a single flagellum which is located at the pole of the coccobacillus. Usually, there are one or two more lateral flagella as well. It is part of the normal flora of water and soil of tropical and sub-tropical regions of the world. It produces a natural antibiotic called violacein, which may be useful for the treatment of colon and other cancers. It grows readily on nutrient agar, producing distinctive smooth low convex colonies with a dark violet metallic sheen (due to violacein production). Some strains of the bacteria which do not produce this pigment have also been reported. It has the ability to break down tarballs.
C. violaceum rarely infects humans, but when it does it causes skin lesions, sepsis, and liver abscesses that may be fatal. The first reported case of Chromobacterium violaceum infection in humans in literature is from Malaysia in 1927. Only 150 cases have been reported in literature since then. To date, cases have been reported from Argentina, Australia, Brazil, Cuba, India, Japan, Nigeria, Singapore, Sri Lanka, Taiwan, United States and Vietnam. The commonest mode of entry of the bacteria into the body is through the injured skin coming in contact with soil or water containing the bacteria. The disease usually starts as a limited infection of the skin at the point of entry of the bacteria, which progresses to necrotizing metastatic lesions, then multiple abscesses of the liver, lung, spleen, skin, lymph nodes or brain, leading to severe septicaemia, culminating in multiorgan failure which may be fatal. Other reported pathologies include chronic granulomatosis, osteomyelitis, cellulitis, diarrhoea, septic spondylitis, conjunctivitis, periorbital and ocular infection. Care must be taken because Burkholderia pseudomallei is commonly misidentified as C. violaceum by many common identification methods. The two are readily distinguished because B. pseudomallei produces large wrinkled colonies, whereas C. violaceum produces a distinctive violet pigment.
C. violaceum produces a number of natural antibiotics:
^Itah AY, Essien JP (2005). "Growth Profile and Hydrocarbonoclastic Potential of Microorganisms Isolated from Tarballs in the Bight of Bonny, Nigeria". World Journal of Microbiology and Biotechnology. 21 (6–7): 1317–22. doi:10.1007/s11274-004-6694-z.
^Chou, YL; Yang ., PY; Huang, CC; Leu, HS; Tsao, TC (2000). "Fatal and non-fatal chromobacterial septicemia: report of two cases". Chang Gung Med J. 23 (8): 492–7. PMID11039252.
^Shao, PL; Hsueh, PR; Chang, YC; Lu, CY; Lee, PY; Lee, CY; Huang, LM (2002). "Chromobacterium violaceum infection in children: a case of fatal septicemia with nasopharyngeal abscess and literature review". Pediatr Infect Dis J. 21 (7): 707–9. doi:10.1097/00006454-200207000-00022. PMID12237610.
^Howard, AJ; Ison, CA (1996). "Haemophilus, Gardnerella and other bacilli". In Collee, JG; Fraser, AG; Marmion, BP; Simmons, A (eds.). Mackie and McCartney Practical Medical Microbiology (14th ed.). New York: Churchill Livingstone. pp. 329–41.